Clinical Trials Logo

Filter by:
  • Enrolling by invitation  
  • « Prev · Page [2]
NCT ID: NCT04618536 Enrolling by invitation - Clinical trials for Sunscreen Persistence

Comparison of Sun Protection Factor 30 Persistence Between Inorganic and Organic Sunscreen in Swimmer

Start date: October 5, 2020
Phase: N/A
Study type: Interventional

Prolonged sunlight exposure in swimming athletes can cause various changes in the skin; among them is sunburn. The use of sunscreen can reduce sunburn effectively. However, various types of physical activity that can trigger sweating, friction, washing with water, or sun exposure after sunscreen use can interfere with its effectiveness in the form of a decreased SPF level. The purpose of this study is to determine and compare the persistence of organic and inorganic sun protection factor 30 (SPF 30) sunscreens after 1.5 hours of swimming.

NCT ID: NCT04337905 Enrolling by invitation - ADHD Clinical Trials

Virtual Reality (VR) Diagnostic Tool for Attention Deficits/Hyperactivity Disorder (ADHD)

New
Start date: May 25, 2019
Phase: N/A
Study type: Interventional

Attention deficit/ hyperactivity disorder (ADHD) is a common neurodevelopmental disorder. The common diagnostic of ADHD is based on psychiatric examination and interview. So far, there is not any other diagnostic tool for ADHD nowadays. Therefore, virtual reality (VR) technology can be used as a stimulus, replacing real stimuli, recreating experiences, which are in the real world would be impossible. Consequently, ADHD-VR diagnostic tool development should be started to justify the ADHD diagnosis in psychiatric out-patient clinical services.

NCT ID: NCT04101136 Enrolling by invitation - CMV Clinical Trials

Effect of Atorvastatin on Subclinical Atherosclerosis

Start date: September 30, 2019
Phase: N/A
Study type: Interventional

Statin administration is supposed to reduce subclinical atherosclerosis by decreasing LDL cholesterol levels, possibly via lipid-independent anti-inflammatory effect. Its pleiotropic properties also adding beneficial effect against CMV infection. The investigators plan to study atorvastatin in virally- suppressed HIV-infected patients on stable ART with CMV seropositive and statin-naïve to evaluate the subclinical atherosclerosis changes assessed by carotid intima media thickness (CIMT).

NCT ID: NCT03895164 Enrolling by invitation - Anemia Clinical Trials

Linear Programming Approach to Develop Local Specific Food-based Complementary Feeding Recommendation

Start date: December 19, 2018
Phase: N/A
Study type: Interventional

Stunting and anemia amongst under-two children are attributable to poor nutrient intakes. The study evaluates the effectiveness of nutrition education on local specific food-based complementary feeding recommendation (CFR) to improve dietary patterns and nutritional intakes, as well as reduce stunting and anemia among under-two children.

NCT ID: NCT02033681 Enrolling by invitation - Ischemia Clinical Trials

Optimal Time Delay of Epinephrine Injection With "One-per-mil" Tumescent Solution

Start date: September 2013
Phase: N/A
Study type: Interventional

The aim of this study is to know the characteristic of "one-per-mil" tumescent solution in regards of the optimal time delay to achieve optimal visualization of operation field in hand and digit surgery. Hypothesis: 1. Epinephine in "one-per-mil" concentration by tumescent injection technique will provide faster decrease in oxygen saturation compared to normal saline solution injected by tumescent technique. 2. Epinephrine in "one-per-mil" concentration by tumescent injection technique will provide effectiveness in vasoconstriction longer than 10 minutes as the optimal time delay. 3. Epinephine in "one-per-mil" concentration by tumescent injection technique causes no finger necrosis as normal saline solution injected by tumescent technique.